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Abstract: A high retention enzymatic bioreactor was developed by coupling membrane distillation
with an enzymatic bioreactor (MD-EMBR) to investigate the degradation of 13 phenolic and
17 non-phenolic trace organic contaminants (TrOCs). TrOCs were effectively retained (90–99%) by
the MD membrane. Furthermore, significant laccase-catalyzed degradation (80–99%) was achieved
for 10 phenolic and 3 non-phenolic TrOCs that contain strong electron donating functional groups.
For the remaining TrOCs, enzymatic degradation ranged from 40 to 65%. This is still higher than those
reported for enzymatic bioreactors equipped with ultrafiltration membranes, which retained laccase
but not the TrOCs. Addition of three redox-mediators, namely syringaldehyde (SA), violuric acid
(VA) and 1-hydroxybenzotriazole (HBT), in the MD-EMBR significantly broadened the spectrum of
efficiently degraded TrOCs. Among the tested redox-mediators, VA (0.5 mM) was the most efficient
and versatile mediator for enhanced TrOC degradation. The final effluent (i.e., membrane permeate)
toxicity was below the detection limit, although there was a mediator-specific increase in toxicity of
the bioreactor media.
Keywords: enzymatic membrane bioreactor (EMBR); laccase; membrane distillation; redox-mediators;
trace organic contaminants (TrOCs)

1. Introduction
Laccase (EC 1.10.3.2), a copper-containing oxidoreductase enzyme, has been studied extensively
for the degradation of recalcitrant compounds such as phenols and aromatic hydrocarbons [1–5].
In recent years, laccase-catalyzed degradation of trace organic contaminants (TrOCs) such as
pharmaceuticals, pesticides, personal care products, industrial chemicals and steroid hormones has
gained significant attention [6,7]. These TrOCs occur ubiquitously in municipal wastewater and have
the potential to adversely affect aquatic ecosystems and human health [8–10].
TrOC degradation by laccase depends on a number of factors including pH, temperature,
chemical structure of TrOCs and laccase properties [11–13]. In general, effective laccase-catalyzed
degradation of TrOCs containing electron donating functional groups (EDGs) such as amine (–NH2 ),
alkoxy (–OR) or hydroxyl (–OH) was observed. On the other hand, degradation of TrOCs containing
electron withdrawing functional groups (EWGs) such as halogen (–X), amide (–CONR2 ) or nitro
Appl. Sci. 2017, 7, 879; doi:10.3390/app7090879
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(–NO2 ) has been reported to be poor or unstable [11,14]. Degradation of TrOCs can be improved by
adding different natural and synthetic redox-mediators that are low molecular weight compounds
capable of exchanging electrons between laccase and TrOCs [15–17].
Initial studies have assessed the performance of laccase-catalyzed TrOC degradation in batch
enzymatic bioreactors due to the concern of enzyme washout in a continuous flow system. In an attempt
to prevent enzyme washout, an enzymatic membrane bioreactor (EMBR) was developed by coupling
an ultrafiltration (UF) membrane to an enzymatic bioreactor [18,19]. Interestingly, during the operation
of the EMBR, adsorption of some hydrophobic TrOCs (e.g., amitriptyline, oxybenzone and octocrylene)
onto the enzyme gel layer over the membrane surface resulted in enhanced degradation of the adsorbed
compounds [18]. In another study, removal of four non-phenolic TrOCs, namely atrazine, sulfamethoxazole,
diclofenac and carbamazepine was improved by 15–25% following the addition of granular activated
carbon (GAC) in EMBR. This was probably because simultaneous adsorption of laccase and TrOCs on
GAC promoted the interaction of TrOCs with the active sites of laccase [20]. Results from previous studies
indicate the complementarity of simultaneous laccase and TrOC retention within EMBR in contrast to only
laccase retention by UF membranes utilized in the previously developed EMBRs. Hence, in this study,
it is postulated that the integration of an enzymatic bioreactor with a high retention membrane could
facilitate the degradation of resistant TrOCs by retaining both laccase and TrOCs.
Different configurations of conventional activated sludge-based high retention membrane
bioreactors (HR-MBR), employing membrane distillation (MD), forward osmosis (FO) or nanofiltration
(NF) membranes, have been investigated for advanced wastewater treatment [21–24]. Complete TrOC
retention in HR-MBR improved the membrane permeate quality, but the poor removal of certain groups
of TrOCs such as those containing EWGs led to their accumulation in the bioreactor. This indicates the
necessity of formulating means to enhance biodegradation of TrOCs. In this context, it is noteworthy
that recent reports confirm enhanced laccase-catalyzed degradation of selected TrOCs that are not
amenable to degradation by conventional activated sludge [25,26]. However, the performance of
a high retention—enzymatic membrane bioreactor for the removal of a wide range of TrOCs remains
to be elucidated.
Among the high retention membrane systems, in MD, a vapor-liquid interface is developed
around a hydrophobic micro-porous membrane that allows the water to pass through the membrane
via diffusion due to vapor pressure gradient. Compared to conventional distillation processes such
as fractional distillation, the MD process requires low temperature and could be operated by using
low grade heat or solar energy [27,28]. Since the mass transfer in the MD process occurs in gaseous
phase, it can theoretically achieve 100% retention of all non-volatile compounds [29]. The standalone
MD process has been investigated for seawater desalination [30], industrial wastewater treatment [31],
municipal wastewater treatment [32] and TrOC removal [29,33]. Thus, the MD process was selected
for coupling to an enzymatic bioreactor in this study.
The aim of this study was to assess the performance of a laccase based membrane distillation—
enzymatic membrane bioreactor (MD-EMBR) for the removal of TrOCs having diverse physicochemical
properties (e.g., EDGs/EWGs, hydrophobicity and phenolic/non-phenolic moieties). A special focus
was given to the improvement in TrOC degradation due to the addition of three redox-mediators,
namely syringaldehyde (SA), violuric acid (VA) and 1-hydroxybenzotriazole (HBT) at different
concentrations. In addition, performance of laccase-mediator systems was systematically compared
based on TrOC degradation, enzyme stability and effluent toxicity.
2. Materials and Methods
2.1. Trace Organic Contaminants (TrOCs), Laccase and Mediators
A set of 30 TrOCs comprising 10 pharmaceuticals, four personal care products, six pesticides,
four industrial chemicals, five steroid hormones and one phytoestrogen was selected based on their
widespread occurrence in surface water bodies (see Supplementary Data Table S1). Key physicochemical
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properties of the TrOCs including molecular weight, water solubility, hydrophobicity (log D) and volatility
(pKH ) are presented in Table 1. All TrOCs were purchased from Sigma Aldrich (Sydney, NSW, Australia),
and were of analytical grade. A stock solution (25 mg/L) containing the mixture of 30 TrOCs was prepared
in pure methanol, and kept in dark at −18 ◦ C.
Laccase from genetically modified Aspergillus oryzae was supplied by Novozymes Australia Pty
Ltd (Sydney, NSW, Australia). According to the supplier, the enzyme has a molecular weight, purity,
activity and density of 56 KDa, 10% (w/w), 150,000 µM(DMP) /min (measured using 2,6-dimethoxy
phenol, DMP, as substrate) and 1.12 g/mL, respectively.
Two N–OH type redox-mediators, namely 1-hydroxybenzotriazole (HBT) and violuric acid
(VA), and one phenolic redox-mediator, namely syringaldehyde (SA), were used in this study (see
Supplementary Data Table S2). The selected mediators all follow hydrogen atom transfer (HAT)
pathway for TrOC degradation [34], but the oxidation of phenolic and N–OH type redox-mediators by
laccase produces highly reactive phenoxyl and aminoxyl radicals, respectively. The mediators were
also purchased from Sigma Aldrich (Sydney, NSW, Australia). A separate stock solution (50 mM) of
each redox-mediator was prepared, and stored at 4 ◦ C in dark.
Table 1. Physicochemical properties of the selected TrOCs.
TrOCs

Chemical
Formula

Molecular Log D at
Weight
pH = 7

Water Solubility
at 25 ◦ C

Vapor
Pressure

mg/L

(mmHg)

1500
554,000
435,000
263,000
29,000
20,000
230,000
928,000
140
100,000
220
0.36
83
69
800
150
1000

6.08 × 10−11
3.32 × 10−8
3.01 × 10−7
6.13 × 10 −7
2.67 × 10−7
1.59 × 10−7
2.13 × 10−6
1.39 × 10−4
1.72 × 10−6
1.03 × 10−4
5.78 × 10−7
2.56 × 10−9
1.50 × 10−6
1.27 × 10−5
1.53 × 10−3
8.23 × 10−4
5.6 × 10−3

13.93
13.70
12.68
12.11
11.68
11.51
11.48
10.39
9.35
9.54
9.09
8.47
8.18
7.28
6.28
5.88
5.85

200
32
3.9
2700
5.9
3
1.9
73
2240
4800
19
1000
62

3.29 × 10−13
1.34 × 10−9
3.74 × 10−9
5.26 × 10−6
1.54 × 10−8
9.82 × 10−9
9.88 × 10−9
5.34 × 10−7
8.2 × 10−5
3.49 × 10−4
3.26 × 10−5
0.0361
1.98 × 10−3

15.20
10.78
9.47
9.23
9.03
8.93
8.67
8.66
8.18
7.59
6.18
5.15
5.06

g/mole

pKH at
pH 7

Non-Phenolic Compounds
Primidone
Ketoprofen
Naproxen
Gemfibrozil
Metronidazole
Diclofenac
Fenoprop
Ibuprofen
Ametryn
Clofibric acid
Carbamazepine
Octocrylene
Amitriptyline
Atrazine
Propoxur
Benzophenone
DEET

C12 H14 N2 O
C16 H14 O3
C14 H14 O3
C15 H22 O3
C6 H9 N3 O3
C14 H11 Cl2 NO2
C9 H7 Cl3 O3
C13 H18 O2
C9 H17 N5 S
C10 H11 ClO3
C15 H12 N2 O
C24 H27 N
C20 H23 N
C8 H14 ClN5
C11 H15 NO3
C13 H10 O
C12 H17 NO

218.25
254.28
230.26
250.33
171.15
296.15
269.51
206.28
27.33
214.65
236.27
361.48
277.40
215.68
209.24
182.22
191.3

0.83
0.19
0.73
2.07
−0.14
1.77
−0.13
0.94
2.97
−1.06
1.89
6.89
2.28
2.64
1.54
3.21
2.42

Phenolic Compounds
Enterolactone
Estriol
17α-Ethinylestradiol
Oxybenzone
Estrone
17β-Estradiol
17β-Estradiol-17-acetate
Bisphenol A
Salicylic acid
Pentachlorophenol
Triclosan
4-tert-Butylphenol
4-tert-Octylphenol

C18 H18 O4
C18 H24 O3
C20 H24 O2
C14 H12 O3
C18 H22 O2
C18 H24 O2
C20 H26 O3
C15 H16 O2
C7 H6 O3
C6 HCl5 O
C12 H7 Cl3 O2
C10 H14 O
C14 H22 O

288.38
298.33
269.40
228.24
270.37
272.38
314.42
228.29
138.12
266.34
289.54
150.22
206.32

2.53
1.89
4.11
3.89
3.62
4.15
5.11
3.64
−1.13
2.85
5.28
3.40
5.18

2.2. Experimental Setup
The laboratory scale MD-EMBR setup comprised a glass enzymatic bioreactor (1.5 L) and
an external direct contact membrane distillation system (Figure 1). The glass enzymatic bioreactor
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covered with aluminum foil was placed in a water bath, and the temperature of the water bath was
maintained at 30 ± 0.2 ◦ C using an immersion heating unit (Julabo, Seelbach, Germany). The enzymatic
bioreactor was equipped with an air pump (ACO-002, Zhejiang Sensen Industry Co. Ltd., Zhoushan,
Appl. Sci. 2017, 7, 879
4 of 15
China)
to maintain a dissolved oxygen concentration of above 3 mg/L.

Figure
1. Schematic
representation
distillation—enzymatic
membrane
bioreactor
Figure
1. Schematic
representationofofthe
themembrane
membrane distillation—enzymatic
membrane
bioreactor
(MD-EMBR).
(MD-EMBR).

The external direct contact membrane distillation system contained an acrylic glass membrane

The external direct contact membrane distillation system contained an acrylic glass membrane
cell, two circulation pumps (Micropump Inc., Vancouver, WA, USA) and a glass permeate tank
cell, two circulation pumps (Micropump Inc., Vancouver, WA, USA) and a glass permeate tank
(Figure 1). Feed and permeate flow channels were engraved on each block of the membrane cell.
(Figure
1). Feed
flow
channels
engraved
each
block of the membrane cell.
Length,
widthand
and permeate
height of each
flow
channelwere
were 145,
95 and 3on
mm,
respectively.
Length, width
and height
of each flow
channel were 145, (PTFE)
95 and membrane
3 mm, respectively.
A hydrophobic
microporous
polytetrafloroethylene
(GE, Minnetonka, MN,
A
hydrophobic
microporous
polytetrafloroethylene
(PTFE)
(GE,size
Minnetonka,
USA)
was used during
each experiment.
The PTFE membrane
hasmembrane
a nominal pore
of 0.22 µm, MN,
of 175
µm, each
porosity
of 70% and The
an active
layer
thicknesshas
of 5 aµm
[35]. pore size of 0.22 µm,
USA)thickness
was used
during
experiment.
PTFE
membrane
nominal
thickness of 175 µm, porosity of 70% and an active layer thickness of 5 µm [35].
2.3. Experimental Protocol

2.3. Experimental
A series Protocol
of experiments was carried out to evaluate the performance of MD-EMBR for TrOC
degradation.
At the start of the
a mixture
of the the
selected
TrOCs (each
20 µg/L) in MilliA
series of experiments
wasexperiment,
carried out
to evaluate
performance
ofatMD-EMBR
for TrOC
Q water was added to the bioreactor. Laccase was added to the bioreactor for achieving an initial
degradation. At the start of the experiment, a mixture of the selected TrOCs (each at 20 µg/L) in
enzymatic activity of 95–100 µM(DMP)/min. The media from the glass enzymatic bioreactor and water
Milli-Q water was added to the bioreactor. Laccase was added to the bioreactor for achieving an initial
from the permeate tank were recirculated in their respective flow channels separated by the
enzymatic
activity
of 95–100
µM(DMP)Thermo
/min. The
mediaWaltham,
from theMA,
glass
enzymatic
bioreactor
and
membrane.
A chiller
(SC100-A10,
Scientific,
USA)
was used
to regulate
thewater
from temperature
the permeate
were recirculated
their
flowtank
channels
separated
byathe
membrane.
oftank
the permeate
tank at 10 in
± 0.1
°C.respective
The permeate
was also
placed on
precision
A chiller
(SC100-A10,
Thermo
Scientific,
Waltham,
MA,
USA)
was
used
to
regulate
the
temperature
balance (Mettler Toledo Inc., Columbus, OH, USA) to monitor permeate flux. The recirculation flow of
◦ C. The
the permeate
tank
10 the
± 0.1
permeate
was also
placed on atoprecision
balance
(Mettler
rate of both
feedatand
distillate
was
controlledtank
at 1 L/min
(corresponding
the cross flow
velocity
of Inc.,
9 cm/s)
using two OH,
rotameters.
Toledo
Columbus,
USA) to monitor permeate flux. The recirculation flow rate of both feed
Duplicate samples from the enzymatic bioreactor (100 mL each) and permeate tank (500 mL
each) were taken after operating the MD-EMBR for 12 h. After evaluating the laccase-catalyzed
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and the distillate was controlled at 1 L/min (corresponding to the cross flow velocity of 9 cm/s) using
two rotameters.
Duplicate samples from the enzymatic bioreactor (100 mL each) and permeate tank (500 mL each)
were taken after operating the MD-EMBR for 12 h. After evaluating the laccase-catalyzed degradation
of TrOCs in MD-EMBR, the possible improvement in TrOC degradation was assessed with the addition
of three redox-mediators (HBT, VA and SA) at two different concentrations (0.25 and 0.5 mM) via
separate runs. Again duplicate samples from the enzymatic bioreactor and permeate tank were
collected for the quantification of TrOCs.
Samples collected from the enzymatic bioreactor were diluted to 500 mL with Milli-Q water and
were filtered through 0.45 µm glass fiber filter paper (Filtech, Wollongong, NSW, Australia). The pH
of samples was adjusted to 2–2.5 using 4 M H2 SO4 before solid phase extraction (SPE) and GC/MS
analysis. For toxicity analysis, undiluted samples from the enzymatic bioreactor and permeate tank
were collected in 2 mL amber vials at the end of each experiment, and stored at 4 ◦ C until analysis.
2.4. Analytical Methods
2.4.1. TrOC Analysis
The concentration of TrOCs was measured using an analytical method involving SPE
derivatization and quantitative determination by a Shimadzu GC/MS (QP5000) system as described
by Hai et al. [36]. Limit of detection (LOD) for this method was compound specific and ranged from
1 to 20 ng/L (see Supplementary Data Table S1). Removal efficiencies by the enzymatic bioreactor (R1 )
and the MD-EMBR (R2 ) were calculated using Equations (1) and (2), respectively:
R1 = 100 × (1 − Cf /Co )

(1)

R2 = 100 × (1 − Cp /Co )

(2)

where, Co and Cf are the concentration (ng/L) of specific TrOC in the enzymatic bioreactor at the
beginning (t = 0 h) and end (t = 12 h) of experiment, respectively, while Cp is the concentration of
specific TrOC in permeate at t = 12 h. The enzymatic transformation/degradation of TrOCs in the
MD-EMBR was calculated using Equation (3):
Co × Vo = (Cf × Vf ) + (Cp × Vp ) + biodegradation

(3)

where, Vo , Vf and Vp represents the volume of feed (at t = 0 h), supernatant (t = 12 h) and permeate
(t = 12 h), respectively.
2.4.2. Enzymatic Activity, ORP and Toxicity Assay
Laccase activity and effluent toxicity were examined as described elsewhere [18]. Laccase activity
was measured by recording the change in absorbance at 468 nm due to the oxidation of 2,6-dimethoxyl
phenol (DMP) in the presence of 100 mM sodium citrate (pH 4.5). Laccase activity expressed as
µM(DMP) /min was then calculated from the molar extinction coefficient of 49.6/mM cm. Oxidation
reduction potential (ORP) was measured at the start and end of each experiment using an ORP meter
(WP-80D dual pH-mV meter, Thermo Fisher Scientific, Scoresby, VIC, Australia). Samples for toxicity
analysis were collected from the enzymatic bioreactor and permeate tank at end of each experiment.
Toxicity, expressed as a relative toxicity unit (rTU), was analyzed by measuring the inhibition
of luminescence in the naturally bioluminescent bacteria, Photobacterium leiognathi, as previously
described [37,38].
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3. Results and Discussion
3.1. Overall Removal of TrOCs
In theory, MD membranes can retain all but the volatile organic compounds. In this study,
the concentration of non-volatile (pKH > 9) TrOCs in the permeate of the MD-EMBR was below the
limit of detection of GC/MS. This is consistent with the observation in a previous study, where an MD
membrane was coupled with an activated sludge bioreactor [22]. On the other hand, the MD system
achieved 90–99% removal of relatively volatile TrOCs having pKH < 9 (Figure 2). This compares
Appl. Sci. 2017, 7, 879
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tert-butylphenol, and 4-tert-octylphenol (87–99%)) and two personal care products (oxybenzone and
17β–estradiol,
and 17β-estradiol-17-acetate
(95–99%)),
two industrial
chemicals
triclosan 17α–ethinylestradiol
(89–98%)). On the other hand,
enzymatic degradation of some
phenolic compounds,
namely
(4-tert-butylphenol,
and enterolactone
4-tert-octylphenol
(87–99%))
and two
personal
care Their
products
(oxybenzone
pentachlorophenol,
and salicylic
acid, ranged
from
55 to 75%.
incomplete
degradation, despite the presence of a strong EDG (i.e., hydroxyl group), can be attributed to the
concomitant presence of an EWG (e.g., halogen) in their molecular structure (see Supplementary Data
Table S1) [39].
Depending on the medium ORP, laccase can also degrade non-phenolic compounds. However,
the reaction kinetics can be slow [17,39]. In this study, the enzymatic degradation of 17 non-phenolic
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and triclosan (89–98%)). On the other hand, enzymatic degradation of some phenolic compounds,
namely pentachlorophenol, enterolactone and salicylic acid, ranged from 55 to 75%. Their incomplete
degradation, despite the presence of a strong EDG (i.e., hydroxyl group), can be attributed to the
concomitant presence of an EWG (e.g., halogen) in their molecular structure (see Supplementary Data
Table S1) [39].
Depending on the medium ORP, laccase can also degrade non-phenolic compounds. However,
the reaction kinetics can be slow [17,39]. In this study, the enzymatic degradation of 17 non-phenolic
TrOCs varied from 40–99% (Figure 2). Laccase catalyzed degradation of 13 compounds fell in the
range of 40–65%, while the degradation of the remaining four TrOCs was in the range of 94–98%.
The well degraded non-phenolic TrOCs include metronidazole, benzophenone, amitriptyline and
octocrylene. High laccase-catalyzed degradation (80–99%) in continuous flow UF-EMBR has been
previously reported [18,37] for benzophenone, amitriptyline and octocrylene, but not for metronidazole.
Metronidazole contains both EWGs (i.e., –NO2 ) and EDGs (i.e., methyl and hydroxyethyl) in its
molecule (see Supplementary Data Table S1). High enzymatic degradation of metronidazole following
its complete retention by the MD membrane in MD-EMBR can be attributed to the prolonged contact
time that may have promoted the interaction of laccase with the EDGs of metronidazole.
An overall degradation of only 40–65% was achieved by the MD-EMBR for a number of
non-phenolic TrOCs (Figure 2), however, these removal efficiencies in fact compare favorably with
those reported in the literature [12,15,37]. For instance, laccase catalyzed degradation of carbamazepine,
clofibric acid, fenoprop and atrazine has been reported to be less than 10% in both batch and continuous
flow ultrafiltration based enzymatic bioreactors [15,18,40]. By contrast, 40–45% degradation of these
TrOCs by the MD-EMBR was observed in this study. Since most of the selected non-phenolic TrOCs
contain both EWGs and EDGs in their structure (see Supplementary Data Table S1), complete retention
of these TrOCs in the enzymatic bioreactor may have facilitated the interaction of EDGs with nearby
redox centers, thereby providing higher possibility of electron transfer to enzyme [17]. Previously,
Nguyen et al. [20] reported that dosing of GAC into an UF-EMBR led to simultaneous adsorption of
laccase and TrOCs on GAC, yielding significant improvement in the degradation of four non-phenolic
TrOCs, namely atrazine, sulfamethoxazole, diclofenac and carbamazepine. Although our approach
was different, it is conceivable that prolonged retention of TrOCs in the enzymatic bioreactor can
improve their degradation.
It is noteworthy that phenolic TrOCs (e.g., triclosan, oxybenzone, bisphenol A and steroid
hormones) can act as redox-mediators, and the fragments of phenoxyl radicals formed following
their degradation by laccase can oxidize non-phenolic compounds [39]. Indeed Margot et al. [12]
observed that degradation of diclofenac by laccase was significantly higher in the mixture of TrOCs
containing diclofenac, bisphenol A and mefenamic acid than its degradation as a single compound.
It is possible that complete retention of phenoxyl radicals formed due to the degradation of phenolic
TrOCs aided better degradation of non-phenolic TrOCs by MD-EMBR as compared to previously
developed UF-EMBR [18,37]. Further investigation would be required to substantiate this hypothesis
but that is beyond the scope of this study.
This study confirms for the first time the improvement in TrOC degradation in an enzymatic
bioreactor by coupling with it a high retention membrane (such as membrane distillation) as compared
to a conventional ultrafiltration membrane. We used a direct contact membrane distillation module,
but there may be case-specific scope of choice between different formats of membrane distillation.
Future studies are recommended to assess the commercial viability of different configurations of MD
such as vacuum MD and air gap MD, but that is beyond the scope of this study.
3.3. Impact of Mediator Addition on TrOC Degradation
As noted in Section 3.2, of the 30 TrOCs tested, MD-EMBR achieved high degradation (85–99%)
for 14 compounds (10 phenolic and 4 non-phenolic compounds) but the degradation efficiency varied
widely (40–70%) for the rest of the compounds. To improve the degradation of the latter group,

Appl. Sci. 2017, 7, 879

8 of 15

three redox-mediators, namely SA, VA and HBT, were added at 0.25 and 0.5 mM concentrations each
in separate runs. Depending on the redox-mediator type and concentration, degradation of phenolic
compounds and non-phenolic compounds by the MD-EMBR was improved by 20–30% and 10–50%,
Appl. Sci.
2017, 7, 879
8 of 15
respectively
(Figure
3) as explained in the following sections.
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Figure 3. Enzymatic degradation of 30 TrOCs in the presence of three mediators, namely HBT, VA

Figure 3. Enzymatic degradation of 30 TrOCs in the presence of three mediators, namely HBT, VA and
and SA (separately at 0.5 mM) in the MD-EMBR. Error bars indicate the standard deviation of
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in the MD-EMBR.
Error
bars indicate
standard
duplicateat
samples.
Operating
conditions of the
MD-EMBR
are giventhe
in the
caption deviation
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3.3.1. Comparison
To date,of
theRedox-Mediators
impact of redox-mediator type on the improvement of TrOC degradation has been
assessed mainly in small scale and batch tests [34,41,42]. For instance, Ashe et al. [34] investigated the

To date, the impact of redox-mediator type on the improvement of TrOC degradation has been
performance of seven different redox-mediators including SA, HBT and VA for the degradation of
assessedfour
mainly
in TrOCs,
small scale
batchnaproxen,
tests [34,41,42].
For
instance,
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and
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at a concentration
of 1 VA
mM.for
Nguyen
et al.
achieved
enhanced
(10–90%)
removalnaproxen,
of TrOCs inoxybenzone
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and HBT. However, this
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resistant
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the
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study
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and
HBT
for
enhanced
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of
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batch reactors. They achieved significant improvement (40–90%) at a concentration of 1 mM.
of TrOCs by an MD-EMBR.
Nguyenspectrum
et al. [18]
achieved enhanced (10–90%) removal of TrOCs in UF-EMBR using SA and HBT.
All the tested redox-mediators enhanced the degradation of TrOCs. However, the best overall
However,
this is the first study investigating the efficacy of SA, VA and HBT for enhanced degradation
performance was shown by VA (Figure 3). In line with the findings of Nguyen et al. [37], degradation
of a broad
spectrum
TrOCs
an already
MD-EMBR.
of the
phenolic of
TrOCs
thatby
were
highly degraded by laccase (Figure 2) remained almost the
Allsame
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salicylic
acid
(80%)
performance was shown by VA (Figure 3). In line with the findings of Nguyen et al. [37], degradation of the
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95% 2)
degradation
enterolactone,
phenolicand
TrOCs
that were already
degraded
by laccase
(Figure
remainedofalmost
the same after
which compares favorably with 45–70% degradation achieved in absence of mediators (Figure 3).
the addition of redox-mediators. For the remaining phenolic TrOCs, VA (at 0.5 mM), compared to HBT
Of the 17 non-phenolic compounds, degradation of four compounds viz metronidazole,
and SA achieved
betteramitriptyline
removal forand
twooctocrylene,
compounds,
acid (80%)
andmediator
pentachlorophenol
benzophenone,
wasnamely
at leastsalicylic
90%, regardless
of the
type
(90%). Both
VA
and
SA
achieved
above
95%
degradation
of
enterolactone,
which
compares
with
(Figure 3). For the remaining compounds, VA (at 0.5 mM) achieved better degradationfavorably
for 10
compared
to in
SAabsence
and HBT.ofSA
(at 0.5 mM)
performed
45–70% compounds
degradation
achieved
mediators
(Figure
3). the best for the degradation of two
namely naproxen
and primidone.
It is well-known
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herbicide atrazine
resistant
Of compounds,
the 17 non-phenolic
compounds,
degradation
of that
four
vizismetronidazole,
to laccase catalyzed degradation [18]. Compared to other redox-mediators, HBT was particularly
benzophenone, amitriptyline and octocrylene, was at least 90%, regardless of the mediator type
efficient (>99%) for the degradation of atrazine. Although a superior ability of VA compared to other
(Figure 3). For the remaining compounds, VA (at 0.5 mM) achieved better degradation for
mediators for the degradation of non-phenolic TrOCs has been reported previously in a batch
10 compounds compared to SA and HBT. SA (at 0.5 mM) performed the best for the degradation of two
compounds, namely naproxen and primidone. It is well-known that the herbicide atrazine is resistant
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to laccase catalyzed degradation [18]. Compared to other redox-mediators, HBT was particularly
efficient (>99%) for the degradation of atrazine. Although a superior ability of VA compared to
other mediators for the degradation of non-phenolic TrOCs has been reported previously in a batch
enzymatic bioreactor spiked with four TrOCs [34], the effectiveness of VA for the degradation of
Appl. Sci. 2017, 7, 879
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a broad spectrum of non-phenolic TrOCs is demonstrated for the first time in this study.
enzymatic bioreactor spiked with four TrOCs [34], the effectiveness of VA for the degradation of a
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In general, the degradation of TrOCs that are easily amenable to laccase (Supplementary data
In general, the degradation of TrOCs that are easily amenable to laccase (Supplementary data
Figure S3) does not improve significantly (less than 5% in this study), while the degradation of resistant
Figure S3) does not improve significantly (less than 5% in this study), while the degradation of resistant
TrOCs (Figure 4) may improve with the increase in mediator concentration, and may reach a plateau
TrOCs (Figure 4) may improve with the increase in mediator concentration, and may reach a plateau
beyond a certain mediator concentration. However, the mediator concentration beyond which no
beyond a certain mediator concentration. However, the mediator concentration beyond which no
improvement occurs may depend on the type of mediators as well as the target TrOCs [41,44].
improvement occurs may depend on the type of mediators as well as the target TrOCs [41,44].
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Trametes trogii following a stepwise increase in the concentration of HBT from 0.1 to 10 mM. In
another study, increasing SA concentration from 0.1 to 1 mM resulted in aggravated inactivation of
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following a stepwise increase in the concentration of HBT from 0.1 to 10 mM. In another study, increasing
SA concentration from 0.1 to 1 mM resulted in aggravated inactivation of laccase from Trametes versicolor [42].
These results suggest that the degree of laccase inactivation is strongly influenced by redox-mediator
concentration. Indeed, loss in laccase activity was increased by 7%, 9% and 11% in MD-EMBR due
to the increase in the concentration of HBT, SA and VA, respectively, from 0.25 to 0.5 mM (Figure 5).
Although laccase activity was greatly affected in the presence of redox-mediators, it was compensated by
the improvement in TrOC degradation (Figure 3). For example, the highest drop in laccase activity was
observed in the presence of VA (Figure 5), but it outperformed SA and HBT in terms of enhanced TrOC
degradation (Figure 3).
3.4. Effluent Toxicity
The charged metabolites and highly reactive radicals produced following the oxidation of
redox-mediators may improve TrOC degradation [18,46], but these can also cause an increase
in effluent toxicity [18,47]. In this study, it was not possible to relate individual metabolites to
specific parent compounds because we investigated a mixture of 30 TrOCs. Hence, the overall
bacterial toxicity of the reaction mixture and permeate was evaluated at the end of each run.
Of the three mediators tested, SA significantly increased the toxicity of the solution in the enzymatic
bioreactor, whereas HBT and VA showed no effect on toxicity levels (Table 2). Compared to the
background toxicity of the mixture of laccase and TrOCs in the enzymatic bioreactor of MD-EMBR
(<1 to 1.8 rTU; n = 2), toxicity in the enzymatic bioreactor due to addition of HBT, VA and SA
ranged from <1 to 1.7 rTU (n = 2), 3.3 to 3.9 rTU (n = 2) and 109 to 116 rTU (n = 2), respectively.
Notably, the final effluent (i.e., membrane permeate) was not toxic to bacteria (<1 rTU) for any of
the enzyme/mediator combinations, indicating that MD not only retained TrOCs and laccase but also
the transformation byproducts and radicals responsible for inducing bacterial toxicity. This is an added
advantage of coupling a high retention membrane to the enzymatic bioreactor.
Table 2. Toxicity of the reactor mixture and permeate following treatment of TrOCs with different
mediators in MD-EMBR, expressed as relative toxic unit (rTU). Mediators were added separately
at a concentration of 0.5 mM. The limit of detection of the toxicity assay was 10% inhibition of
luminescence (i.e., 1 rTU). Toxicity in all permeate samples was below the limit of detection (n = 2).
Reaction Mixture

Toxicity of the Reactor Mixture (rTU)

Toxicity of the Permeate (rTU)

TrOCs + Laccase
TrOCs + Laccase + HBT (0.5 mM)
TrOCs + Laccase + VA (0.5 mM)
TrOCs + Laccase + SA (0.5 mM)

<1–1.8
<1–1.7
3.3–3.9
109–116

<1
<1
<1
<1

3.5. Permeate Flux
The driving force of permeate flux in MD is the difference between feed and distillate temperature.
Ideally, feed and distillate temperature is maintained at over 50 and 20–25 ◦ C, respectively to obtain
a permeate flux of approximately 10 L/m2 h [27,48]. In this study, however, to avoid thermal
inhibition of laccase [46], temperature of the enzymatic reactor and permeate tank was kept at
30 and 10 ◦ C, respectively. A stable permeate flux of around 4 L/m2 h was observed during all
experiments (Supplementary Data Figure S4), suggesting that membrane fouling did not occur
during the operation period. This level of flux is consistent with the feed temperature employed.
Notably, the average permeate flux (Figure 6) for laccase only, laccase-HBT, laccase-VA and laccase-SA
variations was 3.69 ± 0.44 L/m2 h (n = 150), 3.89 ± 0.63 L/m2 h (n = 283), 3.92 ± 0.62 L/m2 h (n = 291)
and 3.86 ± 0.66 L/m2 h (n = 288) LMH, respectively, confirming negligible impact of different type
of mediator addition on membrane flux. In this study, the mass transfer coefficient (Km ) of the
DCMD, which was calculated based on the method described by Nghiem et al. [49], ranged from
1.22 to 1.28 (×10−3 ) L/m2 h Pa. This value is in good agreement with that in previous studies [48,50].
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Thus, this study shows both stable membrane hydraulic performance and improved enzymatic
degradation
of879
TrOCs following their complete retention by the MD membrane.
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runs.

4. Conclusions
Performance of an enzymatic
enzymatic bioreactor integrated with the MD
MD system
system (MD-EMBR)
(MD-EMBR) was
examined
of 13
and and
17 non-phenolic
compounds.
Based on
permeate
quality,
examined for
forthe
theremoval
removal
of phenolic
13 phenolic
17 non-phenolic
compounds.
Based
on permeate
MD-EMBR
achieved
90–99%
TrOC
retention.
Degradation
of
TrOCs
varied
(40–99%)
depending
quality, MD-EMBR achieved 90–99% TrOC retention. Degradation of TrOCs varied (40–99%)
on
their molecular
withdrawing
functional groups
electron
donating
depending
on theirproperties
molecular(electron
properties
(electron withdrawing
functional
groups
electronfunctional
donating
groups
andgroups
phenolic
degradation
(above 90%)
of TrOCs
EDGs inEDGs
their
functional
andmoiety).
phenolicHigh
moiety).
High degradation
(above
90%) ofcontaining
TrOCs containing
chemical
structurestructure
was observed
in the MD-EMBR,
while those
containing
EWGs in their
molecular
in their chemical
was observed
in the MD-EMBR,
while
those containing
EWGs
in their
structure
moderately
(40–75%).
Degradation
of TrOCs
was further
improved
by adding
molecularwere
structure
weredegraded
moderately
degraded
(40–75%).
Degradation
of TrOCs
was
further
three
redox-mediators,
namely
syringaldehyde
(SA), syringaldehyde
violuric acid (VA)
andvioluric
1-hydroxybenzotriazole
improved
by adding three
redox-mediators,
namely
(SA),
acid (VA) and 1(HBT).
VA at 0.5 mM concentration
to be the most was
effective
mediator
for improving
the
hydroxybenzotriazole
(HBT). VA atwas
0.5found
mM concentration
found
to be the
most effective
degradation
phenolic and
TrOCs.
Moreover,
it was observed
thatMoreover,
the degradation
mediator forofimproving
the non-phenolic
degradation of
phenolic
and non-phenolic
TrOCs.
it was
of
non-phenolic
laccase-mediator
system in
was
strongly influenced
thestrongly
tested
observed
that thecompounds
degradation in
of non-phenolic
compounds
laccase-mediator
systemby
was
influenced by the tested concentration of the redox-mediators. Despite an increase in the toxicity of
the reaction mixture caused by SA, the final effluent of the MD-EMBR was nontoxic.
Supplementary Materials: The following are available online at http://www.mdpi.com/2076-3417/7/9/879/s1,
Table S1: Physicochemical properties of the selected trace organic contaminants (TrOCs), Table S2:
Physicochemical properties of the selected redox-mediators, Figure S3: Impact of mediator concentration (0.25
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concentration of the redox-mediators. Despite an increase in the toxicity of the reaction mixture
caused by SA, the final effluent of the MD-EMBR was nontoxic.
Supplementary Materials: The following are available online at http://www.mdpi.com/2076-3417/7/9/879/s1,
Table S1: Physicochemical properties of the selected trace organic contaminants (TrOCs), Table S2: Physicochemical
properties of the selected redox-mediators, Figure S3: Impact of mediator concentration (0.25 and 0.5 mM) on the
degradation of after an incubation time of 12 h in the MD-EMBR. Error bars indicate the standard deviation of
duplicate samples. Degradation of these TrOCs did not improve by increasing mediator concentration, Figure S4:
Permeate flux obtained during the operation of enzymatic membrane distillation (MD-EMBR) with and without
the addition of redox mediators.
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